Credit Suisse Maintains Outperform on Oscar Health, Raises Price Target to $8.5
Portfolio Pulse from richadhand@benzinga.com
Credit Suisse analyst Jonathan Yong has maintained an Outperform rating on Oscar Health (NYSE:OSCR) and raised the price target from $7 to $8.5.
August 09, 2023 | 1:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Credit Suisse has maintained an Outperform rating on Oscar Health and raised the price target from $7 to $8.5, which could positively impact the stock.
The raised price target by Credit Suisse indicates a positive outlook for Oscar Health. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100